Keyphrases
Bile Acids
78%
Gut Microbiota
49%
Metabolomics
31%
Chronic Liver Disease
26%
Bile Acid Profile
25%
Rheumatoid Arthritis
22%
Colorectal Cancer
22%
Hepatocellular Carcinoma
22%
Targeted Proteomics
20%
Non-alcoholic Fatty Liver Disease (NAFLD)
19%
Inflammation
18%
Farnesoid X Receptor
18%
Fibrosis
18%
Gut Microbiome
16%
Healthy Controls
16%
Mass Spectrometry
15%
Acid Activation
14%
Colonic Inflammation
14%
Etiology
14%
Nonalcoholic Steatohepatitis
13%
Ursodeoxycholic Acid
13%
Integrative Analysis
13%
New Biomarkers
12%
Logistic Regression
12%
Hydroxylated
12%
Lipid Metabolism
12%
Tricarboxylic Acid Cycle (TCA cycle)
12%
Microbiome
12%
Aging
12%
Pathobiology
12%
Colitis
12%
CD31
11%
NAD Synthesis
11%
Gut Microbiota Imbalance
11%
Targeted Drugs
11%
New Pattern
11%
Biomarker Classification
11%
Primary Colorectal Cancer
11%
Metabolic Regulation
11%
Chinese Baijiu
11%
Mirabilite
11%
Drug Agents
11%
Biological Agents
11%
Activating Receptors
11%
Cardiac Structural Abnormality
11%
Autophagy Pathway
11%
Reverse Aging
11%
Blood Markers
11%
Blood Logistics
11%
Innate Immunity
11%
Poria Cocos Polysaccharide
11%
Bile Acid Homeostasis
11%
Adaptive Immunity
11%
Multi-omics Study
11%
Asian Patients
11%
Qishen Yiqi Dripping pills
11%
Dysregulation
11%
Liver Fibrosis
11%
Multi-omics Integration
11%
Brew
11%
Bioinformatics
11%
Integrated Network
11%
Corelation
11%
Glycine
11%
Microbial Alteration
11%
Molecular Therapeutics
11%
Catalase
11%
Crude Drug
11%
Pattern Classification
11%
Network Pharmacology
11%
Low Birth Weight
11%
Profiling Method
11%
Molecular Features
11%
Southeast Asian
11%
M2 Macrophage Polarization
11%
Pu-erh Tea
11%
Alcoholic Liver Injury
11%
Precision Medicine
11%
Alcohol
11%
Infectious Diseases
11%
Liver Fibrogenesis
11%
Therapeutic Target
11%
Esophageal Squamous Cell Carcinoma
11%
Artificial Intelligence
11%
Functional Abnormalities
11%
Therapeutic Discovery
11%
Gut Microbiota Metabolism
11%
Baijiu
11%
Major Depressive Disorder
11%
Serum Bile Acids
11%
Potential Correlation
11%
Non-small Cell Lung Cancer Patients
11%
Chinese Medicine
11%
Lung Microbiome
11%
Theabrownin
11%
Patients with Schizophrenia
11%
Molecular Profiling
11%
Host Metabolism
11%
Microarray Technology
11%
Fatty Acid Metabolism
11%
Pharmacology, Toxicology and Pharmaceutical Science
Bile Acid
100%
Intestine Flora
37%
Microbiome
36%
Nonalcoholic Fatty Liver
29%
Inflammation
29%
Chronic Liver Disease
22%
Fibrosis
19%
Ethanol
15%
Farnesoid X Receptor
14%
Liver Injury
13%
Diseases
13%
Ursodeoxycholic Acid
13%
Fatty Acid
13%
Tricarboxylic Acid
12%
Tryptophan
12%
Receptor
12%
Colitis
12%
Colorectal Carcinoma
11%
Hypolipemia
11%
Low Birth Weight
11%
Major Depression
11%
Polysaccharide
11%
Biological Product
11%
Crude Drug
11%
Wolfiporia extensa
11%
Catalase
11%
Congestive Heart Failure
11%
Network Pharmacology
11%
Alcohol Liver Cirrhosis
11%
Peroxisome Proliferator Activated Receptor
11%
Liver Cell Carcinoma
11%
Ferroptosis
11%
Transcription Factor Nrf2
11%
Aromatic Hydrocarbon Receptor
11%
Lung Infection
11%
Liver Fibrosis
9%
Mouse Model
9%
Inflammatory Bowel Disease
8%
Dysbiosis
8%
Liver Disease
7%
Piglet
6%
Microorganism
6%
Disease Exacerbation
5%
Indoleacetic Acid
5%
Disulfiram
5%
Liver Cirrhosis
5%
Medicine and Dentistry
Bile Acid
45%
Hepatocellular Carcinoma
22%
Gut Microbiota
22%
Nonalcoholic Fatty Liver
17%
Fibrosis
14%
Tamsulosin
14%
Homeostasis
13%
Metabolic Disorder
12%
Hypolipemia
11%
Fibrogenesis
11%
Citric Acid Cycle
11%
Logistic Regression Analysis
11%
Biological Product
11%
Chronic Liver Disease
11%
Balloon Occlusion
11%
Uterine Artery Embolization
11%
Adaptive Immunity
11%
Microbiome
11%
Receptor
11%
Colorectal Carcinoma
11%
Metabolome
11%
Esophageal Squamous Cell Carcinoma
11%
Ferroptosis
11%
Lung Infection
11%
Human Study
11%
Transcription Factor Nrf2
11%
Biotransformation
11%
Gut Microbiome
11%
Electron Microscopy
11%
Liver Fibrosis
9%
Curettage
9%
Serum Metabolite
7%
Diseases
7%
Malignant Neoplasm
6%
Liver Disease
5%
Tumor Microenvironment
5%